Track topics on Twitter Track topics that are important to you
Global Antimicrobial Susceptibility Market to reach USD 4.1 billion by 2025.
Global Antimicrobial Susceptibility Market is valued approximately USD 2.7 million in 2017 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 20182025. Antimicrobial Susceptibility is developing and expanding at a significant pace. Antimicrobial susceptibility tests are utilized to determine the specific antibiotics which are used in order to treat a specific type of infection that is caused by fungus or bacteria. Antimicrobial susceptibility testing is pivotal to identify the patients or individuals' antibiotic treatment fight against the antibiotic resistance present in the environment. The Antimicrobial susceptibility is mainly driven owing to rise in number of bacterial fungal infections in both the male and female population on the globe beginning from 2017 to 2025. The factors which includes rise in microbial resistance, need of new broad spectrum antibiotics, surge in number of bacterial infections and increase in awareness about the infection control in healthcare system is fueling the adoption and utility of antimicrobial susceptibility test market on the global scenario. However, inefficient diagnosis, patent expirations, low patient compliance and lack of return on investment along with stringent regulatory norms and policies are the factors which are acting as restraining factors considering the growth of antimicrobial susceptibility market.
The regional analysis of Global Antimicrobial Susceptibility Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the fastest growing region across the world in terms of market share. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is anticipated to be the dominating region over the forecast period 20182025.
The leading market players include
Thermo Fisher Scientific Inc
Becton and Dickinson Company
Alifax Holding S.P.A
Beckman Coulter, Inc
The objective of the study is to define market sizes of different segments countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and subsegment of the market are explained below:
Automated Test System
Broth Dilution Method
Rapid Automated Method
Disk Diffusion Method
Gradient Diffusion Method
Molecular Testing Method
By Test Type:
By End User:
Diagnostic Laboratories and Hospitals
Pharmaceutical and Biotechnology Companies
Research and Academic Institutes
Contract Research Organizations
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year 2015, 2016
Base year 2017
Forecast period 2018 to 2025
Target Audience of the Global Antimicrobial Susceptibility Market in Market Study:
Key Consulting Companies Advisors
Large, mediumsized, and small enterprises
ValueAdded Resellers VARs
Thirdparty knowledge providers
Original Article: Global Antimicrobial Susceptibility Market Size study, by Type Tests Kits, Culture Media, Automated Test System, Consumables, by Method Broth Dilution Method, Rapid Automated Method, Disk Diffusion Method, Gradient Diffusion Method, Molecular Testing MetNEXT ARTICLE
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...
MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16 account for 96% of MRSA blood...